한글목차

세계 해부 병리학 시장 규모는 2025년부터 2032년까지 연평균 7.9%의 성장률로 크게 확대될 것으로 예상됩니다. 시장 규모는 2025년 40억 7,000만 달러에서 2032년 말 69억 3,000만 달러로 확대될 것으로 예상되며, 진단 기술 발전, 만성질환의 유병률 증가, 노인 인구 증가가 그 요인으로 작용할 것으로 보입니다.

해부 병리학은 병리학 중에서도 중요한 분야로, 질병을 규명하기 위해 조직과 세포를 현미경으로 연구하는 분야입니다. 이 분야는 조직병리학, 세포학, 면역조직화학 등의 기술을 도입하여 조직의 구조적, 기능적 변화를 분석합니다. 치료 접근법을 유도하고, 환자의 예후를 예측하며, 다양한 질병에 대한 이해를 높이는 데 중요한 역할을 하고 있습니다. 헬스케어 분야가 새로운 기술과 인구통계학적 변화와 함께 진화하는 가운데, 해부학적 병리학은 진단과 치료 의사결정의 핵심이 되고 있습니다.

영상 진단, 분자병리학, 자동화의 눈부신 발전으로 진단의 정확성과 효율성이 향상되고 있습니다. 디지털 병리학의 도입으로 슬라이드의 디지털화, 원격 협업, AI 기반 분석이 가능해져 보다 신속하고 정확한 진단이 가능해졌습니다.

세계의 해부 병리학 시장에 대해 조사했으며, 시장 개요와 함께 제품 및 서비스별, 용도별, 최종 용도별, 지역별 동향, 시장 진입 기업의 경쟁 동향 등의 정보를 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의와 세분화
• 시장 역학
• 밸류체인 분석
• Porter's Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나·러시아 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 세계의 해부 병리학 시장 전망, 2019-2032년

• 세계의 해부 병리학 시장 전망, 제품 및 서비스별, 금액(10억 달러), 2019-2032년
• 세계의 해부 병리학 시장 전망, 용도별, 금액(10억 달러), 2019-2032년
• 세계의 해부 병리학 시장 전망, 최종 용도별, 금액(10억 달러), 2019-2032년
• 세계의 해부 병리학 시장 전망, 지역별, 금액(10억 달러), 2019-2032년

제4장 북미의 해부 병리학 시장 전망, 2019-2032년

제5장 유럽의 해부 병리학 시장 전망, 2019-2032년

제6장 아시아태평양의 해부 병리학 시장 전망, 2019-2032년

제7장 라틴아메리카의 해부 병리학 시장 전망, 2019-2032년

제8장 중동 및 아프리카의 해부 병리학 시장 전망, 2019-2032년

제9장 경쟁 구도

• 기업 시장 점유율 분석, 2025년
• 경쟁 대시보드
• 기업 개요
  • BioGenex
  • Cardinal Health, Inc.
  • Sakura Finetek USA, Inc.
  • Quest Diagnostics Incorporated
  • Agilent Technologies
  • Bio SB
  • F. Hoffmann-La Roche AG
  • NeoGenomics
  • Laboratory Corporation of America Holdings

제10장 부록

영문목차

The global anatomic pathology market is poised for substantial expansion, projected to grow at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032. The market size is anticipated to rise from US$4.07 billion in 2025 to US$6.93 billion by the end of 2032, driven by technological advancements in diagnostics, increasing prevalence of chronic diseases, and a growing elderly population.

Understanding Anatomic Pathology

Anatomic pathology is a crucial discipline within pathology that involves the microscopic study of tissues and cells for disease identification. This field incorporates techniques such as histopathology, cytology, and immunohistochemistry to analyze structural and functional changes in tissues. It plays an essential role in guiding treatment approaches, predicting patient prognoses, and deepening the understanding of various diseases. As the healthcare sector evolves with new technologies and demographic shifts, anatomic pathology remains a cornerstone of diagnostic and therapeutic decision-making.

Market Insights

Key Drivers of Growth:

1.Innovations in Diagnostic Technologies:

• Significant progress in imaging, molecular pathology, and automation has led to improved diagnostic precision and efficiency.
• The adoption of digital pathology allows for slide digitization, remote collaboration, and AI-driven analysis, enabling faster and more accurate diagnoses.

2.Increasing Disease Burden:

• The rising prevalence of cancer and other chronic conditions is fueling demand for precise and timely pathology services.
• A growing aging population, more vulnerable to health issues, is further accelerating market growth.

Challenges Impacting the Market:

1.Telepathology Implementation and Regulatory Complexities:

• While remote diagnostics and collaborative pathology offer numerous benefits, diverse regulatory requirements related to data privacy and diagnostic accuracy pose challenges.

2.Barriers to Technological Integration:

• High costs, interoperability concerns, and the need for specialized staff training make the transition from conventional pathology to digital platforms more complex.

Business Opportunities

Advancements in Diagnostic Solutions:

• The integration of digital pathology, AI, and molecular diagnostic techniques enhances diagnostic precision and operational efficiency.
• AI-driven algorithms expedite data interpretation, generating actionable insights and reducing turnaround times.

Strategic Research Collaborations:

• Partnerships between pathology labs, research institutions, and pharmaceutical firms drive innovation in diagnostic methodologies.
• Collaborative efforts in biomarker discovery and companion diagnostics contribute to the growth of personalized medicine.

Regional Outlook

North America:

• Leads the global market with a well-developed healthcare system, widespread disease awareness, and substantial investment in diagnostic technologies.
• The U.S. has recorded a 24.3% increase in the adoption of advanced pathology services over the past three years, reinforcing market expansion.

Europe:

• Pioneers in implementing advanced diagnostic technologies, with strong backing from research collaborations.
• Nations like the UK emphasize sustainability and standardized pathology procedures, cementing Europe's position as a significant market player.

South Asia & Pacific:

• Emerging as the fastest-growing region, driven by the rapid enhancement of healthcare infrastructure and rising disease prevalence.
• Greater awareness of preventive healthcare practices is boosting demand for pathology services.

Latin America and Middle East & Africa:

• These regions are experiencing steady growth due to improved healthcare accessibility and expanding diagnostic capabilities.

Competitive Landscape

Leading Market Players:

• Laboratory Corporation of America Holdings
• Quest Diagnostics Incorporated
• Sakura Finetek USA, Inc.
• F. Hoffmann-La Roche AG
• Cardinal Health, Inc.
• BioGenex
• NeoGenomics
• Bio SB
• Agilent Technologies

Market Segmentation

By Product and Service:

• Anatomic Pathology Instruments
• Anatomic Pathology Consumables
• Anatomic Pathology Services

By Application:

• Disease Diagnosis
• Drug Discovery and Development
• Other Applications

By End-User:

• Hospitals
• Research Laboratories
• Diagnostic Laboratories
• Other Facilities

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Anatomic Pathology Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value, 2025
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Global Anatomic Pathology Market Outlook, 2019 - 2032

• 3.1. Global Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 - 2032
  • 3.1.1. Key Highlights
    • 3.1.1.1. Anatomic Pathology Instruments
    • 3.1.1.2. Anatomic Pathology Consumables
    • 3.1.1.3. Anatomic Pathology Services
• 3.2. Global Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 - 2032
  • 3.2.1. Key Highlights
    • 3.2.1.1. Disease Diagnosis
    • 3.2.1.2. Drug Discovery and Development
    • 3.2.1.3. Others
• 3.3. Global Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032
  • 3.3.1. Key Highlights
    • 3.3.1.1. Hospitals
    • 3.3.1.2. Research Laboratories
    • 3.3.1.3. Diagnostic Laboratories
    • 3.3.1.4. Others
• 3.4. Global Anatomic Pathology Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
  • 3.4.1. Key Highlights
    • 3.4.1.1. North America
    • 3.4.1.2. Europe
    • 3.4.1.3. Asia Pacific
    • 3.4.1.4. Latin America
    • 3.4.1.5. Middle East & Africa

4. North America Anatomic Pathology Market Outlook, 2019 - 2032

• 4.1. North America Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 - 2032
  • 4.1.1. Key Highlights
    • 4.1.1.1. Anatomic Pathology Instruments
    • 4.1.1.2. Anatomic Pathology Consumables
    • 4.1.1.3. Anatomic Pathology Services
• 4.2. North America Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 - 2032
  • 4.2.1. Key Highlights
    • 4.2.1.1. Disease Diagnosis
    • 4.2.1.2. Drug Discovery and Development
    • 4.2.1.3. Others
• 4.3. North America Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032
  • 4.3.1. Key Highlights
    • 4.3.1.1. Hospitals
    • 4.3.1.2. Research Laboratories
    • 4.3.1.3. Diagnostic Laboratories
    • 4.3.1.4. Others
• 4.4. North America Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
  • 4.4.1. Key Highlights
    • 4.4.1.1. Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 4.4.1.2. Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 4.4.1.3. Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 4.4.1.4. Canada Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 4.4.1.5. Canada Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 4.4.1.6. Canada Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
  • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Anatomic Pathology Market Outlook, 2019 - 2032

• 5.1. Europe Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 - 2032
  • 5.1.1. Key Highlights
    • 5.1.1.1. Anatomic Pathology Instruments
    • 5.1.1.2. Anatomic Pathology Consumables
    • 5.1.1.3. Anatomic Pathology Services
• 5.2. Europe Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 - 2032
  • 5.2.1. Key Highlights
    • 5.2.1.1. Disease Diagnosis
    • 5.2.1.2. Drug Discovery and Development
    • 5.2.1.3. Others
• 5.3. Europe Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032
  • 5.3.1. Key Highlights
    • 5.3.1.1. Hospitals
    • 5.3.1.2. Research Laboratories
    • 5.3.1.3. Diagnostic Laboratories
    • 5.3.1.4. Others
• 5.4. Europe Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
  • 5.4.1. Key Highlights
    • 5.4.1.1. Germany Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 5.4.1.2. Germany Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 5.4.1.3. Germany Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 5.4.1.4. U.K. Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 5.4.1.5. U.K. Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 5.4.1.6. U.K. Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 5.4.1.7. France Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 5.4.1.8. France Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 5.4.1.9. France Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 5.4.1.10. Italy Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 5.4.1.11. Italy Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 5.4.1.12. Italy Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 5.4.1.13. Turkey Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 5.4.1.14. Turkey Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 5.4.1.15. Turkey Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 5.4.1.16. Russia Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 5.4.1.17. Russia Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 5.4.1.18. Russia Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 5.4.1.19. Rest of Europe Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 5.4.1.20. Rest of Europe Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 5.4.1.21. Rest of Europe Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
  • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Anatomic Pathology Market Outlook, 2019 - 2032

• 6.1. Asia Pacific Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 - 2032
  • 6.1.1. Key Highlights
    • 6.1.1.1. Anatomic Pathology Instruments
    • 6.1.1.2. Anatomic Pathology Consumables
    • 6.1.1.3. Anatomic Pathology Services
• 6.2. Asia Pacific Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 - 2032
  • 6.2.1. Key Highlights
    • 6.2.1.1. Disease Diagnosis
    • 6.2.1.2. Drug Discovery and Development
    • 6.2.1.3. Others
• 6.3. Asia Pacific Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032
  • 6.3.1. Key Highlights
    • 6.3.1.1. Hospitals
    • 6.3.1.2. Research Laboratories
    • 6.3.1.3. Diagnostic Laboratories
    • 6.3.1.4. Others
• 6.4. Asia Pacific Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
  • 6.4.1. Key Highlights
    • 6.4.1.1. China Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 6.4.1.2. China Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 6.4.1.3. China Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 6.4.1.4. Japan Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 6.4.1.5. Japan Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 6.4.1.6. Japan Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 6.4.1.7. South Korea Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 6.4.1.8. South Korea Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 6.4.1.9. South Korea Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 6.4.1.10. India Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 6.4.1.11. India Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 6.4.1.12. India Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 6.4.1.13. Southeast Asia Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 6.4.1.14. Southeast Asia Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 6.4.1.15. Southeast Asia Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 6.4.1.16. Rest of Asia Pacific Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 6.4.1.17. Rest of Asia Pacific Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 6.4.1.18. Rest of Asia Pacific Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
  • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Anatomic Pathology Market Outlook, 2019 - 2032

• 7.1. Latin America Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 - 2032
  • 7.1.1. Key Highlights
    • 7.1.1.1. Anatomic Pathology Instruments
    • 7.1.1.2. Anatomic Pathology Consumables
    • 7.1.1.3. Anatomic Pathology Services
• 7.2. Latin America Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 - 2032
  • 7.2.1. Key Highlights
    • 7.2.1.1. Disease Diagnosis
    • 7.2.1.2. Drug Discovery and Development
    • 7.2.1.3. Others
• 7.3. Latin America Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032
  • 7.3.1. Key Highlights
    • 7.3.1.1. Hospitals
    • 7.3.1.2. Research Laboratories
    • 7.3.1.3. Diagnostic Laboratories
    • 7.3.1.4. Others
• 7.4. Latin America Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
  • 7.4.1. Key Highlights
    • 7.4.1.1. Brazil Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 7.4.1.2. Brazil Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 7.4.1.3. Brazil Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 7.4.1.4. Mexico Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 7.4.1.5. Mexico Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 7.4.1.6. Mexico Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 7.4.1.7. Argentina Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 7.4.1.8. Argentina Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 7.4.1.9. Argentina Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 7.4.1.10. Rest of Latin America Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 7.4.1.11. Rest of Latin America Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 7.4.1.12. Rest of Latin America Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
  • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Anatomic Pathology Market Outlook, 2019 - 2032

• 8.1. Middle East & Africa Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 - 2032
  • 8.1.1. Key Highlights
    • 8.1.1.1. Anatomic Pathology Instruments
    • 8.1.1.2. Anatomic Pathology Consumables
    • 8.1.1.3. Anatomic Pathology Services
• 8.2. Middle East & Africa Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 - 2032
  • 8.2.1. Key Highlights
    • 8.2.1.1. Disease Diagnosis
    • 8.2.1.2. Drug Discovery and Development
    • 8.2.1.3. Others
• 8.3. Middle East & Africa Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032
  • 8.3.1. Key Highlights
    • 8.3.1.1. Hospitals
    • 8.3.1.2. Research Laboratories
    • 8.3.1.3. Diagnostic Laboratories
    • 8.3.1.4. Others
• 8.4. Middle East & Africa Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
  • 8.4.1. Key Highlights
    • 8.4.1.1. GCC Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 8.4.1.2. GCC Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 8.4.1.3. GCC Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 8.4.1.4. South Africa Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 8.4.1.5. South Africa Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 8.4.1.6. South Africa Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 8.4.1.7. Egypt Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 8.4.1.8. Egypt Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 8.4.1.9. Egypt Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 8.4.1.10. Nigeria Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 8.4.1.11. Nigeria Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 8.4.1.12. Nigeria Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 8.4.1.13. Rest of Middle East & Africa Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
    • 8.4.1.14. Rest of Middle East & Africa Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
    • 8.4.1.15. Rest of Middle East & Africa Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
  • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

• 9.1. Company Market Share Analysis, 2025
• 9.2. Competitive Dashboard
• 9.3. Company Profiles
  • 9.3.1. BioGenex
    • 9.3.1.1. Company Overview
    • 9.3.1.2. Product and Service Portfolio
    • 9.3.1.3. Financial Overview
    • 9.3.1.4. Business Strategies and Development
  • 9.3.2. Cardinal Health, Inc.
    • 9.3.2.1. Company Overview
    • 9.3.2.2. Product and Service Portfolio
    • 9.3.2.3. Financial Overview
    • 9.3.2.4. Business Strategies and Development
  • 9.3.3. Sakura Finetek USA, Inc.
    • 9.3.3.1. Company Overview
    • 9.3.3.2. Product and Service Portfolio
    • 9.3.3.3. Financial Overview
    • 9.3.3.4. Business Strategies and Development
  • 9.3.4. Quest Diagnostics Incorporated
    • 9.3.4.1. Company Overview
    • 9.3.4.2. Product and Service Portfolio
    • 9.3.4.3. Financial Overview
    • 9.3.4.4. Business Strategies and Development
  • 9.3.5. Agilent Technologies
    • 9.3.5.1. Company Overview
    • 9.3.5.2. Product and Service Portfolio
    • 9.3.5.3. Financial Overview
    • 9.3.5.4. Business Strategies and Development
  • 9.3.6. Bio SB
    • 9.3.6.1. Company Overview
    • 9.3.6.2. Product and Service Portfolio
    • 9.3.6.3. Financial Overview
    • 9.3.6.4. Business Strategies and Development
  • 9.3.7. F. Hoffmann-La Roche AG
    • 9.3.7.1. Company Overview
    • 9.3.7.2. Product and Service Portfolio
    • 9.3.7.3. Financial Overview
    • 9.3.7.4. Business Strategies and Development
  • 9.3.8. NeoGenomics
    • 9.3.8.1. Company Overview
    • 9.3.8.2. Product and Service Portfolio
    • 9.3.8.3. Financial Overview
    • 9.3.8.4. Business Strategies and Development
  • 9.3.9. Laboratory Corporation of America Holdings
    • 9.3.9.1. Company Overview
    • 9.3.9.2. Product and Service Portfolio
    • 9.3.9.3. Financial Overview
    • 9.3.9.4. Business Strategies and Development

10. Appendix

• 10.1. Research Methodology
• 10.2. Report Assumptions
• 10.3. Acronyms and Abbreviations